NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/18/2026 09:44
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11.1 mln
Float14.66 mln
Earnings Date08/14/2026
EPS
0.03
Marginal
P / E
21.33
Premium valuation
Beneish M-Score
-3.2
Reliable
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.05
Debt-free
ROE
-11.29
Negative
Business Description
OSR Holdings Inc. is a Bellevue, Washington-based healthcare company operating across the United States, Switzerland, and South Korea. The company is advancing a range of cancer treatments, including VXM01, which is currently in Phase 2 clinical trials for brain cancer, alongside several earlier-stage therapies targeting various tumor types. OSR Holdings is also developing biologics aimed at spinal fusion and osteoarthritis, and distributes medical devices used in neurovascular procedures.
